Clinical Trial Disclosure and Data Transparency Conference
Learn about the latest requirements in clinical trial disclosure and data transparency, share best practices, and engage in in-depth discussions on hot topics.
Session 7: Sharing Patient Level Data: Where Are We Headed?
Marla Jo Brickman, PhD
Senior Director - Clinical Data Transparency/Compassionate Access Lead
Pfizer Inc, United States
The sharing of patient-level data has now become the new norm. Provisions for sponsors of clinical research (industry, academia, government) are being added to regulations and guidelines requiring these sponsors to make the de-identified/anonymized data supporting this clinical research available to other researchers. In this session, we will discuss the practical implications of current data sharing models, as well as, explore future models and what this means for the research community, government, industry, and academia.
Learning Objective :
Explain current models for the sharing of patient-level data
Recognize proposals for future models for the sharing of patient-level data
Interpret first-hand accounts in sharing/using patient-level data
Sean Khozin, MD, MPH
Global Head of Data Strategy
Janssen Research & Development, LLC, United States
Rebecca Li, PhD
Vivli Center for Global Clinical Research Data, United States